Solid organ transplant: medication management issues.

Abstract

Solid organ transplant patients are surviving longer today with a better quality of life. Although the incidence of acute rejection has decreased sharply in the past decade, chronic rejection remains an important problem. Goals for immunosuppression should focus equally on prevention of rejection and post-transplant complications. Newer and more specific immunosuppressive agents are available that can improve patient outcomes with fewer adverse effects. Pharmacists can help to prevent post-transplant complications and improve outcomes with immunosuppressive therapy.